<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hanoun M</submitter><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>365-375</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4156919</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(3)</volume><pubmed_abstract>Perivascular mesenchymal stem and progenitor cells (MSPCs) are critical for forming a healthy hematopoietic stem cell (HSC) niche. However, the interactions and influence of acute myelogenous leukemia (AML) stem cells with the microenvironment remain largely unexplored. We have unexpectedly found that neuropathy of the sympathetic nervous system (SNS) promotes leukemic bone marrow infiltration in an MLL-AF9 AML model. Development of AML disrupts SNS nerves and the quiescence of Nestin(+) niche cells, leading to an expansion of phenotypic MSPCs primed for osteoblastic differentiation at the expense of HSC-maintaining NG2(+) periarteriolar niche cells. Adrenergic signaling promoting leukemogenesis is transduced by the β2, but not β3, adrenergic receptor expressed on stromal cells of leukemic</pubmed_abstract><journal>Cell stem cell</journal><pubmed_title>Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche.</pubmed_title><pmcid>PMC4156919</pmcid><funding_grant_id>GM007491</funding_grant_id><funding_grant_id>DK056638</funding_grant_id><funding_grant_id>HL097819</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>CA66996</funding_grant_id><funding_grant_id>R01 CA140575</funding_grant_id><funding_grant_id>HL116340</funding_grant_id><funding_grant_id>R01 DK056638</funding_grant_id><funding_grant_id>CA140575</funding_grant_id><funding_grant_id>T32 GM007491</funding_grant_id><funding_grant_id>P30 CA013330</funding_grant_id><funding_grant_id>P01 CA066996</funding_grant_id><funding_grant_id>R01 HL116340</funding_grant_id><funding_grant_id>R01 HL097819</funding_grant_id><pubmed_authors>Armstrong SA</pubmed_authors><pubmed_authors>Pinho S</pubmed_authors><pubmed_authors>Zhang D</pubmed_authors><pubmed_authors>Frenette PS</pubmed_authors><pubmed_authors>Hanoun M</pubmed_authors><pubmed_authors>Pierce H</pubmed_authors><pubmed_authors>Kunisaki Y</pubmed_authors><pubmed_authors>Lacombe J</pubmed_authors><pubmed_authors>Mizoguchi T</pubmed_authors><pubmed_authors>Duhrsen U</pubmed_authors></additional><is_claimable>false</is_claimable><name>Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche.</name><description>Perivascular mesenchymal stem and progenitor cells (MSPCs) are critical for forming a healthy hematopoietic stem cell (HSC) niche. However, the interactions and influence of acute myelogenous leukemia (AML) stem cells with the microenvironment remain largely unexplored. We have unexpectedly found that neuropathy of the sympathetic nervous system (SNS) promotes leukemic bone marrow infiltration in an MLL-AF9 AML model. Development of AML disrupts SNS nerves and the quiescence of Nestin(+) niche cells, leading to an expansion of phenotypic MSPCs primed for osteoblastic differentiation at the expense of HSC-maintaining NG2(+) periarteriolar niche cells. Adrenergic signaling promoting leukemogenesis is transduced by the β2, but not β3, adrenergic receptor expressed on stromal cells of leukemic</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Sep</publication><modification>2025-04-19T08:54:34.632Z</modification><creation>2019-03-27T01:35:20Z</creation></dates><accession>S-EPMC4156919</accession><cross_references><pubmed>25017722</pubmed><doi>10.1016/j.stem.2014.06.020</doi></cross_references></HashMap>